Table 3.
Entity | Reactome Pathway Name | Size | ES | NES | p-Value | FDR q-Value |
---|---|---|---|---|---|---|
Genes | Glucuronidation | 15 | −0.84 | −2.13 | <0.001 | <0.001 |
Chondroitin sulfate dermatan sulfate metabolism | 42 | −0.57 | −1.76 | 0.002 | 0.088 | |
Gap junction trafficking | 25 | −0.59 | −1.65 | 0.002 | 0.228 | |
G β: γ signalling through PI3Kgamma | 24 | −0.59 | −1.65 | 0.003 | 0.191 | |
Activation of kainate receptors upon glutamate binding | 29 | −0.55 | −1.60 | 0.008 | 0.236 | |
Immunoregulatory interactions between a lymphoid and a non-lymphoid cell | 58 | 0.31 | 1.49 | <0.001 | 0.246 | |
Promoters | Regulation of β cell development | 27 | −0.64 | −1.92 | <0.001 | 0.022 |
Regulation of gene expression in β cells | 17 | −0.64 | −1.75 | 0.002 | 0.200 | |
Immunoregulatory interactions between a lymphoid and a non-lymphoid cell | 33 | 0.53 | 2.20 | <0.001 | 0.007 |
Pathways with a false discovery rate (FDR) ≤0.25 are shown. Size, number of pathway genes available for analysis; ES, enrichment score for pathway; NES, normalized enrichment score for pathway.